-
PHS 2022-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
(PA-22-176)
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of General Medical Sciences
National Cancer Institute
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Library of Medicine
National Institute of Mental Health
National Institute of Nursing Research
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
Food and Drug Administration
National Center for Environmental Health
National Center for Injury Prevention and Control
National Institute for Occupational Safety and Health
National Institute on Minority Health and Health Disparities
National Center for Advancing Translational Sciences
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): Standard dates apply
-
PHS 2022-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
(PA-22-177)
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of General Medical Sciences
National Cancer Institute
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute of Mental Health
National Institute of Nursing Research
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
National Center for Environmental Health
National Center for Injury Prevention and Control
National Institute for Occupational Safety and Health
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): Standard dates apply
-
PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
(PA-22-178)
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of Allergy and Infectious Diseases
National Institute of Arthritis and Musculoskeletal and Skin Diseases
National Institute of General Medical Sciences
National Cancer Institute
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Dental and Craniofacial Research
National Institute of Diabetes and Digestive and Kidney Diseases
National Institute of Environmental Health Sciences
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Library of Medicine
National Institute of Mental Health
National Institute of Nursing Research
National Institute of Neurological Disorders and Stroke
National Center for Advancing Translational Sciences
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
National Institute on Minority Health and Health Disparities
National Center for Advancing Translational Sciences
Division of Program Coordination, Planning and Strategic Initiatives, Office of Research Infrastructure Programs
Application Receipt Date(s): Standard dates apply
-
PHS 2022-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
(PA-22-179)
National Institutes of Health
National Institute on Alcohol Abuse and Alcoholism
National Institute on Aging
National Institute of General Medical Sciences
National Cancer Institute
National Institute on Drug Abuse
National Institute on Deafness and Other Communication Disorders
National Institute of Environmental Health Sciences
National Eye Institute
Eunice Kennedy Shriver National Institute of Child Health and Human Development
National Human Genome Research Institute
National Heart, Lung, and Blood Institute
National Institute of Mental Health
National Institute of Nursing Research
National Center for Complementary and Integrative Health
National Institute of Biomedical Imaging and Bioengineering
National Institute on Minority Health and Health Disparities
Application Receipt Date(s): Standard dates apply
-
NHLBI TOPMed: Omics Phenotypes of Heart, Lung, and Blood Disorders (X01 - Clinical Trial Not Allowed)
(PAR-22-194)
National Heart, Lung, and Blood Institute
Application Receipt Date(s): October 17, 2024
-
Transformative Research on the Basic Mechanisms of Polysubstance use in Addiction (R01 - Clinical Trial Not Allowed)
(RFA-DA-23-015)
National Institute on Drug Abuse
Application Receipt Date(s): November 14, 2022
-
Cooperative Agreement to Support an Evidence-Based Clinical Practice Guideline for the Safe Tapering of Benzodiazepines (U01) Clinical Trials Not Allowed
(RFA-FD-22-027)
Food and Drug Administration
Application Receipt Date(s): August 3, 2022
-
Cooperative Agreement to Support an Evidence-Based Clinical Practice Guideline for the Management of Postoperative Pain After Surgeries in Obstetric Patients (U01) Clinical Trials Not Allowed
(RFA-FD-22-028)
Food and Drug Administration
Application Receipt Date(s): August 3, 2022